...BAX licensed worldwide rights, excluding Japan and certain other regions, to market and distribute ANP's CoSeal...

...distribute ANP's CoSeal surgical sealant and Adhibit surgical anti-adhesive product. BAX will immediately begin marketing CoSeal...

...distribute Angiotech's CoSeal surgical sealant and Adhibit surgical anti-adhesive product. BAX will immediately begin marketing CoSeal...

...ANP began an open-label European study in 30 patients undergoing a lung resection. CoSeal will be...
...air leaks. The company said the study could be used to expand the European label. CoSeal...
...was acquired by ANP earlier this month. Angiotech Pharmaceuticals Inc. (TSE:ANP; ANPI), Vancouver, B.C. Product: CoSeal...

...ANPI plans to combine its device-coating technology with CSON's biomaterials, which include the marketed products CoSeal...

...for coating devices with therapeutics, such as paclitaxel-coated stents, with CSON's biomaterials. CSON markets its CoSeal...

...for coating devices with therapeutics, such as paclitaxel-coated stents, with CSON's biomaterials. CSON markets its CoSeal...

...CSON filed for an expanded European label of CoSeal to include adhesion prevention. The product already...
...EU and elsewhere as a vascular sealant. Cohesion Technologies Inc. (CSON), Palo Alto, Calif. Product: CoSeal...

...CoSeal reduced post-surgical adhesions compared to control. Secondary follow-up surgery is still required for 8 CoSeal...
...expanded labeling for CoSeal to prevent adhesion. Cohesion Technologies Inc. (CSON), Palo Alto, Calif. Product: CoSeal...

...CSON launched in the U.S. its CoSeal synthetic vascular sealing agent to achieve adjunctive hemostasis in...
...to achieve adjunctive hemostasis in surgical closure. Cohesion Technologies Inc. (CSON), Palo Alto, Calif. Product: CoSeal...